InvestorsHub Logo
Followers 6
Posts 112
Boards Moderated 0
Alias Born 06/27/2020

Re: IH Admin [Shelly] post# 337034

Wednesday, 07/21/2021 11:35:01 AM

Wednesday, July 21, 2021 11:35:01 AM

Post# of 424003
Good Morning IH Admin.

Regarding your BOARD WARNING.

Amarin's drug Vascepa/Vazkepa is currently being evaluated in Argentina to understand if it may reduce inflammation related to Covid 19. This is very important if it can reduce Covid 19 deaths and prevent serious illness.

The Covid 19 conversation is very important to Amarin, it's stock holders and, and cardiovascular medicine. This is not politically motivated.

The results of the Argentina trial; "PREPARE-IT" are scheduled to be announced at the European Society of Cardiology (ESC) during its largest Congress Meeting; August 27-30th.

I'm sure Amarin, it's IH retail investor community, and the world will be watching and reporting once the results are communicted.

This should not be considered political banter.....

Thank you,
Retired 2019
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News